184 related articles for article (PubMed ID: 30930249)
1. TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition.
Zandi Z; Kashani B; Poursani EM; Bashash D; Kabuli M; Momeny M; Mousavi-Pak SH; Sheikhsaran F; Alimoghaddam K; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2019 Jun; 853():256-263. PubMed ID: 30930249
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid).
Kashani B; Zandi Z; Bashash D; Zaghal A; Momeny M; Poursani EM; Pourbagheri-Sigaroodi A; Mousavi SA; Ghaffari SH
Cancer Chemother Pharmacol; 2020 Jan; 85(1):47-59. PubMed ID: 31786654
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.
Kashani B; Zandi Z; Karimzadeh MR; Bashash D; Nasrollahzadeh A; Ghaffari SH
Immunol Res; 2019 Dec; 67(6):505-516. PubMed ID: 32026322
[TBL] [Abstract][Full Text] [Related]
4. The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer.
Zandi Z; Kashani B; Bashash D; Poursani EM; Mousavi SA; Chahardoli B; Ghaffari SH
J Cell Biochem; 2020 Feb; 121(2):1623-1634. PubMed ID: 31535397
[TBL] [Abstract][Full Text] [Related]
5. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Li M; Li P; Zhang M; Ma F
Chin J Integr Med; 2018 Jan; 24(1):40-46. PubMed ID: 28795388
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.
Wang W; Wang J
Med Sci Monit; 2018 Aug; 24():5588-5597. PubMed ID: 30098292
[TBL] [Abstract][Full Text] [Related]
7. Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion.
Seol MA; Park JH; Jeong JH; Lyu J; Han SY; Oh SM
Oncotarget; 2017 Jun; 8(25):40190-40203. PubMed ID: 28212583
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation.
Baakhlagh S; Kashani B; Zandi Z; Bashash D; Moradkhani M; Nasrollahzadeh A; Yaghmaei M; Mousavi SA; Ghaffari SH
Int Immunopharmacol; 2021 Jan; 90():107202. PubMed ID: 33278749
[TBL] [Abstract][Full Text] [Related]
9. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
10. Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-κB-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Lee WT; Lee TH; Cheng CH; Chen KC; Chen YC; Lin CW
Food Chem Toxicol; 2015 Apr; 78():33-41. PubMed ID: 25656647
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway.
Feng D; Zhao T; Yan K; Liang H; Liang J; Zhou Y; Zhao W; Ling B
Oncol Rep; 2017 Aug; 38(2):1091-1098. PubMed ID: 28677781
[TBL] [Abstract][Full Text] [Related]
12. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.
Akbarzadeh M; Movassaghpour AA; Ghanbari H; Kheirandish M; Fathi Maroufi N; Rahbarghazi R; Nouri M; Samadi N
Sci Rep; 2017 Dec; 7(1):17062. PubMed ID: 29213108
[TBL] [Abstract][Full Text] [Related]
13. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
14. 27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3.
Shen Z; Zhu D; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y
Environ Toxicol Pharmacol; 2017 Apr; 51():1-8. PubMed ID: 28257824
[TBL] [Abstract][Full Text] [Related]
15. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D
BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531
[TBL] [Abstract][Full Text] [Related]
16. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
Tsai PC; Fu YS; Chang LS; Lin SR
Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
18. α-Lipoic acid prevents the ionizing radiation-induced epithelial-mesenchymal transition and enhances the radiosensitivity in breast cancer cells.
Tripathy J; Chowdhury AR; Prusty M; Muduli K; Priyadarshini N; Reddy KS; Banerjee B; Elangovan S
Eur J Pharmacol; 2020 Mar; 871():172938. PubMed ID: 31958458
[TBL] [Abstract][Full Text] [Related]
19. Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement.
Dinicola S; Masiello MG; Proietti S; Coluccia P; Fabrizi G; Catizone A; Ricci G; de Toma G; Bizzarri M; Cucina A
J Cell Physiol; 2018 Jun; 233(6):4935-4948. PubMed ID: 29215713
[TBL] [Abstract][Full Text] [Related]
20. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
